Evidence map›Paper›PMID 34392713›Full record

ArticleLaboratory animals2022

Voluntary oral dosing for precise experimental compound delivery in adult rats.

Kyle C Chesler, Cara T Motz, Katie L Bales, Rachael A Allen, Harrison K Vo, Machelle T Pardue

Open access · greenAbstract read
In one paragraph

Article in Laboratory animals, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Chewable Tablets for Precise Unit Dosing of Animals.Journal of pharmaceutical innovation · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kyle C CheslerCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center, USA.
Cara T MotzCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center, USA.
Katie L BalesCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center, USA.
Rachael A AllenCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center, USA.
Harrison K VoCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center, USA.
Machelle T PardueCenter of Excellence for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Medical Center, USA.ORCID https://orcid.org/0000-0001-8738-6839
Georgia Institute of Technology · USVeterans Health Administration · USEmory University · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Detecting Early Stage Diabetic RetinopathyI01RX000951 · VA · VETERANS HEALTH ADMINISTRATION · PI PARDUE, MACHELLE T. · 2015 to 2016
–
Dopamine treatments for diabetic retinopathyI01RX002615 · VA · VETERANS HEALTH ADMINISTRATION · PI PARDUE, MACHELLE T. · 2018 to 2021
–
Neuroprotective strategies for retinopathy and cognition in diabetesIK2RX002928 · VA · VETERANS HEALTH ADMINISTRATION · PI ALLEN, RACHAEL STEWART · 2019 to 2023
–
RR&D Research Career Scientist Award ApplicationIK6RX003134 · VA · VETERANS HEALTH ADMINISTRATION · PI PARDUE, MACHELLE T. · 2019 to 2025
–
NCATS NIH HHS UL1 TR002378NEI NIH HHS T32 EY007092RRD VA I01 RX000951RRD VA I01 RX002615RRD VA IK2 RX002928RRD VA IK6 RX003134
6 · The paper itself

Abstract

Preclinical drug studies routinely administer experimental compounds to animal models with the goal of minimizing potential adverse events from the procedure. In this study, we assessed the ability to train adult male Long Evans rats to accept daily voluntarily syringe feedings of l-3,4-dihydroxyphenylalanine (L-DOPA) compared to intraperitoneal (IP) injections. Rats were trained to become familiar with the syringe and then fed a training solution that did not contain the experimental compound. If the rat was compliant during the training phase, the dilution of training solution was continuously decreased and replaced with the experimental solution. Voluntary oral dosing compliance was recorded and quantified throughout the study. To assess drug activity within the drug-targeted tissues, the striatum and retina were collected and analyzed for L-DOPA, dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels by high performance liquid chromatography (HPLC). Drug delivery efficiency by oral dosing was directly compared to IP injection by collecting plasma and analyzing L-DOPA levels with HPLC. Adult male rats had high compliance for voluntary oral dosing. HPLC showed that oral administration of the compound at the same dose as IP injection yielded significantly lower plasma levels, and that higher oral L-DOPA doses yield higher plasma L-DOPA content. This study describes detailed methodology to train adult rats to syringe feed experimental compounds and provides important preclinical research on drug dosing and drug delivery to the striatum and retina.

Indexed as

DopamineLevodopa3,4-Dihydroxyphenylacetic AcidAnimalsCorpus StriatumMaleRatsRats, Long-Evans3,4-Dihydroxyphenylacetic AcidDopamineLevodopa3Rsalternativesdosing/samplingFeedingrefinementrodents

Identifiers

PMID34392713
PMCPMC8841520
OpenAlexW3195906406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.